Single Cell Technology

Single Cell Technology is a leading antibody discovery service provider with a groundbreaking platform that accelerates processes and captures all available data. It has developed a technology for analyzing antibodies and mRNA in cells, called AbTheneum. The company works closely with pharmaceutical companies and CROs to validate AbTheneum and ensure it delivers real-world benefits to customers and consumers. A major breakthrough occurred in 2015 when the end-to-end capability of AbTheneum to perform parallel sequencing of cells and their respective secreted antibodies was first demonstrated.